H. Pitot

Statistics

Publications

Citations

H-Index

Active since

2004

Affiliations

University of North Carolina at Chapel Hill(Current)

Dana-Farber Cancer Institute

Iowa Oncology Research Association

H. Pitot is an author at University of North Carolina at Chapel Hill specializing in chemotherapy dosing adjustments, 5-fluorouracil treatment, and oncology.

Publications per year

2004–2004

Publications

N9741: FOLFOX (oxaliplatin(Oxal)/ 5-fluorouracil (5-FU)/ leucovorin (LV) or reduced dose R-IFL (CPT-11 + 5-FU/LV) in advanced colorectal cancer (CRC): Final efficacy data from an intergroup study

Richard M. Goldberg, Daniel J. Sargent, Roscoe F. Morton et al. · Journal of Clinical Oncology · 2004 · 62 citations

Pharmacy, Oncology, Pharmacotherapy +14

N9741: FOLFOX (oxaliplatin(Oxal)/ 5-fluorouracil (5-FU)/ leucovorin (LV) or reduced dose R-IFL (CPT-11 + 5-FU/LV) in advanced colorectal cancer (CRC): Final efficacy data from an intergroup study

Richard M. Goldberg, Daniel J. Sargent, Roscoe F. Morton et al. · Journal of Clinical Oncology · 2004 · 17 citations

Pharmacy, Oncology, Pharmacotherapy +14

1–2 of 2